Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) insider Jason Ehrlich sold 2,282 shares of the firm’s stock in a transaction on Friday, June 17th. The shares were sold at an average price of $7.02, for a total transaction of $16,019.64. Following the completion of the transaction, the insider now owns 56,920 shares in the company, […]
Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) Director Bros. Advisors Lp Baker purchased 223,766 shares of Kodiak Sciences stock in a transaction dated Wednesday, May 18th. The stock was bought at an average price of $5.97 per share, for a total transaction of $1,335,883.02. Following the completion of the transaction, the director now directly owns […]
Kodiak Sciences (NASDAQ:KOD – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Valuation & Earnings This table compares Kodiak Sciences and […]
Kodiak Sciences (NASDAQ:KOD – Get Rating)‘s stock had its “buy” rating reiterated by equities research analysts at Chardan Capital in a note issued to investors on Monday, Zacks.com reports. Other equities research analysts have also recently issued research reports about the company. Barclays dropped their price objective on Kodiak Sciences from $81.00 to $50.00 and […]
Analysts expect Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) to post earnings per share of ($1.47) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Kodiak Sciences’ earnings. The highest EPS estimate is ($0.73) and the lowest is ($1.80). Kodiak Sciences reported earnings per share of ($0.98) during the […]